Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Malaria Journal|April 14, 2018
Malaria incidence and prevalence during the first year of life in Nanoro, Burkina Faso: a birth-cohort studyHamtandi Magloire Natama, Eduard Rovira-Vallbona, M Athanase Somé, et al.
The Journal of Infectious Diseases|April 17, 2018
Additional Screening and Treatment of Malaria During Pregnancy Provides Further Protection Against Malaria and Nonmalarial Fevers During the First Year of LifeHamtandi Magloire Natama, Eduard Rovira-Vallbona, Hermann Sorgho, et al.
BMC Medicine|November 3, 2018
Modulation of innate immune responses at birth by prenatal malaria exposure and association with malaria risk during the first year of lifeHamtandi Magloire Natama, Gemma Moncunill, Eduard Rovira-Vallbona, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 30, 2025
The clinical significance of monocyte-to-lymphocyte and neutrophil-to-lymphocyte ratios in malaria infection and parasitaemia among pregnant women in Nanoro, Burkina FasoOusmane Traore, Biébo Bihoun, Fatoumata Toumani Koné, et al.
Infection and Immunity|September 27, 2023
Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina FasoHamtandi Magloire Natama, Gemma Moncunill, Marta Vidal, et al.
Lancet (London, England)|February 4, 2024
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trialMehreen S Datoo, Alassane Dicko, Halidou Tinto, et al.
The Lancet. Infectious Diseases|September 10, 2022
Efficacy and immunogenicity of R21/Matrix-M vaccine against clinical malaria after 2 years' follow-up in children in Burkina Faso: a phase 1/2b randomised controlled trialMehreen S Datoo, Hamtandi Magloire Natama, Athanase Somé, et al.
Pageof 2